Back to: products

Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity

PrintEmail
Aug 2020 - 199 Pages - From $3,800
(Excel Data Sheet: $1,800)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global digital biomarkers market will reach $22.54 billion by 2030, growing by 36.2% annually over 2020-2030 driven by rising demand for mobile health apps, elevated level of smartphone and wearable technology in healthcare.
Highlighted with 91 tables and 99 figures, this 199-page report “Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global digital biomarkers market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital biomarkers market in every aspect of the classification from perspectives of System Component, Therapeutic Area, Application, Development Status, End User, and Region.

Based on System Component, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Data Collection Tools
• Digital Platforms
• Mobile Apps
• Desktop-based Software
• Wearables
• Biosensors
Data Integration Systems

Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Cardiovascular Diseases
Neurodegenerative Disorders
• Parkinson’s Disease
• Multiple Sclerosis
• Alzheimer’s Disease
Sleep and Movement Diseases
Psychiatric Disorders
Chronic Pain
Gastrointestinal Diseases
Diabetes
Respiratory Conditions
Other Diseases

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Wellness
• Disease Diagnosis
• Personalised Medication
• Drug Discovery and Development

Based on Development Status, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Novel Digital Biomarkers
• Original Digital Biomarkers
• Approved Digital Biomarkers

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Biopharmaceutical Companies & Labs
• Healthcare Providers
• Insurance Payers

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, The Netherlands, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Spain, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, Israel)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by System Component, Therapeutic Area, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global digital biomarkers market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Actigraph LLC 
Akili Interactive Labs 
AliveCor Inc 
Altoida Inc 
Amgen Inc 
Bayer AG 
Biogen Inc 
Cambridge Cognition Plc 
Eli Lilly and Company 
Evidation Health, Inc. 
F. Hoffmann-La Roche Ltd 
Fitbit Inc 
GlaxoSmithKline Plc 
Happify Health 
Human API 
IXICO Plc 
Koninklijke Philips N.V. 
Medical Care Corporation 
Medopad Ltd 
Mindstrong Health 
Neurotrack Technology, Inc 
Novartis International AG 
Pfizer Inc. 
Quanterix Corporation 
Sanofi S.A. 
The Takeda Pharmaceuticals Company Limited 
Verily Life Sciences 
Winterlight Labs Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on the Market 28
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 44
3 Segmentation of Global Market by System Component 48
3.1 Market Overview by System Component 48
3.2 Data Collection Tools 50
3.2.1 Digital Platforms 52
3.2.2 Mobile Apps 53
3.2.3 Desktop-based Software 54
3.2.4 Wearables 55
3.2.5 Biosensors 56
3.3 Data Integration Systems 57
4 Segmentation of Global Market by Therapeutic Area 58
4.1 Market Overview by Therapeutic Area 58
4.2 Cardiovascular Diseases 60
4.3 Neurodegenerative Disorders 61
4.3.1 Parkinson’s Disease 63
4.3.2 Multiple Sclerosis 64
4.3.3 Alzheimer’s Disease 65
4.4 Sleep and Movement Diseases 66
4.5 Psychiatric Disorders 67
4.6 Chronic Pain 68
4.7 Gastrointestinal Diseases 69
4.8 Diabetes 70
4.9 Respiratory Conditions 71
4.10 Other Diseases 72
5 Segmentation of Global Market by Application 73
5.1 Market Overview by Application 73
5.2 Wellness 75
5.3 Disease Diagnosis 76
5.4 Personalised Medication 77
5.5 Drug Discovery and Development 78
6 Segmentation of Global Market by Development Status 80
6.1 Market Overview by Development Status 80
6.2 Novel Digital Biomarkers 83
6.3 Original Digital Biomarkers 84
6.4 Approved Digital Biomarkers 85
7 Segmentation of Global Market by End User 86
7.1 Market Overview by End User 86
7.2 Biopharmaceutical Companies & Labs 88
7.3 Healthcare Providers 89
7.4 Insurance Payers 90
8 Segmentation of Global Market by Region 91
8.1 Geographic Market Overview 2019-2030 91
8.2 North America Market 2019-2030 by Country 95
8.2.1 Overview of North America Market 95
8.2.2 U.S. 99
8.2.3 Canada 103
8.2.4 Mexico 105
8.3 European Market 2019-2030 by Country 107
8.3.1 Overview of European Market 107
8.3.2 Germany 111
8.3.3 UK 113
8.3.4 France 115
8.3.5 Netherlands 117
8.3.6 Italy 119
8.3.7 Russia 121
8.3.8 Rest of European Market 123
8.4 Asia-Pacific Market 2019-2030 by Country 125
8.4.1 Overview of Asia-Pacific Market 125
8.4.2 Japan 129
8.4.3 China 132
8.4.4 Australia 134
8.4.5 India 136
8.4.6 South Korea 138
8.4.7 Rest of APAC Region 140
8.5 South America Market 2019-2030 by Country 142
8.5.1 Argentina 145
8.5.2 Brazil 147
8.5.3 Chile 149
8.5.4 Rest of South America Market 151
8.6 MEA Market 2019-2030 by Country 152
8.6.1 UAE 155
8.6.2 Saudi Arabia 157
8.6.3 Israel 159
8.6.4 Other National Markets 161
9 Competitive Landscape 162
9.1 Overview of Key Vendors 162
9.2 New Product Launch, Partnership, Investment, and M&A 166
9.3 Company Profiles 167
Actigraph LLC 167
Akili Interactive Labs 169
AliveCor Inc 170
Altoida Inc 171
Amgen Inc 172
Bayer AG 173
Biogen Inc 174
Cambridge Cognition Plc 175
Eli Lilly and Company 176
Evidation Health, Inc. 177
F. Hoffmann-La Roche Ltd 178
Fitbit Inc 179
GlaxoSmithKline Plc 180
Happify Health 181
Human API 182
IXICO Plc 183
Koninklijke Philips N.V. 184
Medical Care Corporation 185
Medopad Ltd 186
Mindstrong Health 187
Neurotrack Technology, Inc 188
Novartis International AG 189
Pfizer Inc. 190
Quanterix Corporation 191
Sanofi S.A. 192
The Takeda Pharmaceuticals Company Limited 193
Verily Life Sciences 194
Winterlight Labs Inc. 195
10 Investing in Global Market: Risk Assessment and Management 196
10.1 Risk Evaluation of Global Market 196
10.2 Critical Success Factors (CSFs) 199
Related Reports and Products 199

List of Tables:

Table 1.  Snapshot of Global Digital Biomarkers Market, 2019-2030 21
Table 2. Overview of Traditional and Digital Biomarker Features, Novel Applications, and Published Examples 25
Table 3. World Smartphone Connections, Average Network Connection Speed for Smartphones and Tablets, 2019-2030 33
Table 4. World Mobile Data Traffic by Deployment Mode, 2019-2030, EB/year 34
Table 5. World Mobile Data Traffic by Device, 2019-2030, EB/year 34
Table 6. Current Challenges of Digital Biomarkers in Medical Settings 37
Table 7.  Main Product Trends and Market Opportunities in Global Digital Biomarkers Market 40
Table 8. Global Digital Biomarkers Market by System Component, 2019-2030, $ mn 48
Table 9. Global Digital Biomarkers Market: Data Collection Tools by Type, 2019-2030, $ mn 51
Table 10. Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 58
Table 11. Global Digital Biomarkers Market: Neurodegenerative Disorders by Type, 2019-2030, $ mn 62
Table 12. Global Digital Biomarkers Market by Application, 2019-2030, $ mn 73
Table 13. Global Digital Biomarkers Market by Development Status, 2019-2030, $ mn 81
Table 14. Global Digital Biomarkers Market by End User, 2019-2030, $ mn 86
Table 15. Global Digital Biomarkers Market by Region, 2019-2030, $ mn 92
Table 16.  Leading National Digital Biomarkers Market, 2019 and 2030, $ mn 94
Table 17. North America Digital Biomarkers Market by Country, 2019-2030, $ mn 97
Table 18. U.S. Digital Biomarkers Market by System Component, 2019-2030, $ mn 101
Table 19. U.S. Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 101
Table 20. U.S. Digital Biomarkers Market by End User, 2019-2030, $ mn 101
Table 21. Canada Digital Biomarkers Market by System Component, 2019-2030, $ mn 104
Table 22. Canada Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 104
Table 23. Canada Digital Biomarkers Market by End User, 2019-2030, $ mn 104
Table 24. Mexico Digital Biomarkers Market by System Component, 2019-2030, $ mn 106
Table 25. Mexico Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 106
Table 26. Mexico Digital Biomarkers Market by End User, 2019-2030, $ mn 106
Table 27. Europe Digital Biomarkers Market by Country, 2019-2030, $ mn 110
Table 28. Germany Digital Biomarkers Market by System Component, 2019-2030, $ mn 112
Table 29. Germany Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 112
Table 30. Germany Digital Biomarkers Market by End User, 2019-2030, $ mn 112
Table 31. UK Digital Biomarkers Market by System Component, 2019-2030, $ mn 114
Table 32. UK Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 114
Table 33. UK Digital Biomarkers Market by End User, 2019-2030, $ mn 114
Table 34. France Digital Biomarkers Market by System Component, 2019-2030, $ mn 116
Table 35. France Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 116
Table 36. France Digital Biomarkers Market by End User, 2019-2030, $ mn 116
Table 37. Netherlands Digital Biomarkers Market by System Component, 2019-2030, $ mn 118
Table 38. Netherlands Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 118
Table 39. Netherlands Digital Biomarkers Market by End User, 2019-2030, $ mn 118
Table 40. Italy Digital Biomarkers Market by System Component, 2019-2030, $ mn 120
Table 41. Italy Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 120
Table 42. Italy Digital Biomarkers Market by End User, 2019-2030, $ mn 120
Table 43. Russia Digital Biomarkers Market by System Component, 2019-2030, $ mn 122
Table 44. Russia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 122
Table 45. Russia Digital Biomarkers Market by End User, 2019-2030, $ mn 122
Table 46. Digital Biomarkers Market in Rest of Europe by Country, 2019-2030, $ mn 124
Table 47. APAC Digital Biomarkers Market by Country, 2019-2030, $ mn 127
Table 48. Japan Digital Biomarkers Market by System Component, 2019-2030, $ mn 131
Table 49. Japan Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 131
Table 50. Japan Digital Biomarkers Market by End User, 2019-2030, $ mn 131
Table 51. China Digital Biomarkers Market by System Component, 2019-2030, $ mn 133
Table 52. China Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 133
Table 53. China Digital Biomarkers Market by End User, 2019-2030, $ mn 133
Table 54. Australia Digital Biomarkers Market by System Component, 2019-2030, $ mn 135
Table 55. Australia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 135
Table 56. Australia Digital Biomarkers Market by End User, 2019-2030, $ mn 135
Table 57. India Digital Biomarkers Market by System Component, 2019-2030, $ mn 137
Table 58. India Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 137
Table 59. India Digital Biomarkers Market by End User, 2019-2030, $ mn 137
Table 60. South Korea Digital Biomarkers Market by System Component, 2019-2030, $ mn 139
Table 61. South Korea Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 139
Table 62. South Korea Digital Biomarkers Market by End User, 2019-2030, $ mn 139
Table 63. Digital Biomarkers Market in Rest of APAC by Country, 2019-2030, $ mn 141
Table 64. South America Digital Biomarkers Market by Country, 2019-2030, $ mn 144
Table 65. Argentina Digital Biomarkers Market by System Component, 2019-2030, $ mn 146
Table 66. Argentina Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 146
Table 67. Argentina Digital Biomarkers Market by End User, 2019-2030, $ mn 146
Table 68. Brazil Digital Biomarkers Market by System Component, 2019-2030, $ mn 148
Table 69. Brazil Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 148
Table 70. Brazil Digital Biomarkers Market by End User, 2019-2030, $ mn 148
Table 71. Chile Digital Biomarkers Market by System Component, 2019-2030, $ mn 150
Table 72. Chile Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 150
Table 73. Chile Digital Biomarkers Market by End User, 2019-2030, $ mn 150
Table 74. MEA Digital Biomarkers Market by Country, 2019-2030, $ mn 154
Table 75. UAE Digital Biomarkers Market by System Component, 2019-2030, $ mn 156
Table 76. UAE Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 156
Table 77. UAE Digital Biomarkers Market by End User, 2019-2030, $ mn 156
Table 78. Saudi Arabia Digital Biomarkers Market by System Component, 2019-2030, $ mn 158
Table 79. Saudi Arabia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 158
Table 80. Saudi Arabia Digital Biomarkers Market by End User, 2019-2030, $ mn 158
Table 81. Israel Digital Biomarkers Market by System Component, 2019-2030, $ mn 160
Table 82. Israel Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn 160
Table 83. Israel Digital Biomarkers Market by End User, 2019-2030, $ mn 160
Table 84. Breakdown of Global Market by Key Vendor, 2019, % 164
Table 85. Actigraph LLC: Company Snapshot 167
Table 86. Actigraph LLC: Business Segmentation 167
Table 87. Actigraph LLC: Product Portfolio 168
Table 88. Actigraph LLC: Revenue, 2016-2018, $ mn 168
Table 89. Actigraph LLC: Recent Developments 168
Table 90.  Risk Evaluation for Investing in Global Market, 2019-2030 197
Table 91. Critical Success Factors and Key Takeaways 200

 


List of Figures:

Figure 1. Research Method Flow Chart 14
Figure 2. Breakdown of Primary Research 16
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20
Figure 5. Global Digital Biomarkers Market, 2019-2030, $ mn 23
Figure 6. Category and Relationship of Traditional Biomarkers and Digital Biomarkers 24
Figure 7. Benefits and Challenges of Digital Biomarkers 26
Figure 8. Global Biomarkers Market, 2019-2030, $ mn 27
Figure 9. Share of Digital Biomarkers in Total Biomarkers Market, 2019-2030 27
Figure 10. Impact of COVID-19 on Business 28
Figure 11. Primary Drivers and Impact Factors of Global Digital Biomarkers Market 30
Figure 12. World 5G Traffic, 2019-2030, EB/year 33
Figure 13. Primary Restraints and Impact Factors of Global Digital Biomarkers Market 35
Figure 14. Data Security Risk in Various User Groups of Digital Biomarkers 38
Figure 15. Pathway to Regulatory Approval of Digital Biomarkers 39
Figure 16. Investment Opportunity Analysis 41
Figure 17. Porter’s Fiver Forces Analysis of Global Digital Biomarkers Market 44
Figure 18. Breakdown of Global Digital Biomarkers Market by System Component, 2019-2030, % of Revenue 49
Figure 19. Global Addressable Market Cap in 2020-2030 by System Component, Value ($ mn) and Share (%) 49
Figure 20. Global Digital Biomarkers Market: Data Collection Tools, 2019-2030, $ mn 50
Figure 21. Global Digital Biomarkers Market: Digital Platforms, 2019-2030, $ mn 52
Figure 22. Global Digital Biomarkers Market: Mobile Apps, 2019-2030, $ mn 53
Figure 23. Global Digital Biomarkers Market: Desktop-based Software, 2019-2030, $ mn 54
Figure 24. Global Digital Biomarkers Market: Wearables, 2019-2030, $ mn 55
Figure 25. Global Digital Biomarkers Market: Biosensors, 2019-2030, $ mn 56
Figure 26. Global Digital Biomarkers Market: Data Integration Systems, 2019-2030, $ mn 57
Figure 27. Breakdown of Global Digital Biomarkers Market by Therapeutic Area, 2019-2030, % of Sales Revenue 59
Figure 28. Global Addressable Market Cap in 2020-2030 by Therapeutic Area, Value ($ mn) and Share (%) 59
Figure 29. Global Digital Biomarkers Market: Cardiovascular Diseases, 2019-2030, $ mn 60
Figure 30. Global Digital Biomarkers Market: Neurodegenerative Disorders, 2019-2030, $ mn 61
Figure 31. Global Digital Biomarkers Market: Parkinson’s Disease, 2019-2030, $ mn 63
Figure 32. Global Digital Biomarkers Market: Multiple Sclerosis, 2019-2030, $ mn 64
Figure 33. Global Digital Biomarkers Market: Alzheimer’s Disease, 2019-2030, $ mn 65
Figure 34. Global Digital Biomarkers Market: Sleep and Movement Diseases, 2019-2030, $ mn 66
Figure 35. Global Digital Biomarkers Market: Psychiatric Disorders, 2019-2030, $ mn 67
Figure 36. Global Digital Biomarkers Market: Chronic Pain, 2019-2030, $ mn 68
Figure 37. Global Digital Biomarkers Market: Gastrointestinal Diseases, 2019-2030, $ mn 69
Figure 38. Global Digital Biomarkers Market: Diabetes, 2019-2030, $ mn 70
Figure 39. Global Digital Biomarkers Market: Respiratory Conditions, 2019-2030, $ mn 71
Figure 40. Global Digital Biomarkers Market: Other Diseases, 2019-2030, $ mn 72
Figure 41. Breakdown of Global Digital Biomarkers Market by Application, 2019-2030, % of Sales Revenue 74
Figure 42. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 74
Figure 43. Global Digital Biomarkers Market: Wellness, 2019-2030, $ mn 75
Figure 44. Global Digital Biomarkers Market: Disease Diagnosis, 2019-2030, $ mn 76
Figure 45. Global Digital Biomarkers Market: Personalised Medication, 2019-2030, $ mn 77
Figure 46. Global Digital Biomarkers Market: Drug Discovery and Development, 2019-2030, $ mn 78
Figure 47. Classification of Digital Biomarkers by Development Status 80
Figure 48. Breakdown of Global Digital Biomarkers Market by Development Status, 2019-2030, % of Revenue 82
Figure 49. Global Addressable Market Cap in 2020-2030 by Development Status, Value ($ mn) and Share (%) 82
Figure 50. Global Digital Biomarkers Market: Novel Digital Biomarkers, 2019-2030, $ mn 83
Figure 51. Global Digital Biomarkers Market: Original Digital Biomarkers, 2019-2030, $ mn 84
Figure 52. Global Digital Biomarkers Market: Approved Digital Biomarkers, 2019-2030, $ mn 85
Figure 53. Breakdown of Global Digital Biomarkers Market by End User, 2019-2030, % of Revenue 87
Figure 54. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 87
Figure 55. Global Digital Biomarkers Market: Biopharmaceutical Companies & Labs, 2019-2030, $ mn 88
Figure 56. Global Digital Biomarkers Market: Healthcare Providers, 2019-2030, $ mn 89
Figure 57. Global Digital Biomarkers Market: Insurance Payers, 2019-2030, $ mn 90
Figure 58.  Global Market Snapshot by Region 91
Figure 59.  Geographic Spread of Worldwide Digital Biomarkers Market, 2019-2030, % of Sales Revenue 92
Figure 60. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%) 93
Figure 61.  North American Digital Biomarkers Market, 2019-2030, $ mn 96
Figure 62. Breakdown of North America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 97
Figure 63. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 98
Figure 64. U.S. Digital Biomarkers Market, 2019-2030, $ mn 100
Figure 65. Canada Digital Biomarkers Market, 2019-2030, $ mn 103
Figure 66.  Digital Biomarkers Market in Mexico, 2015-2030, $ mn 105
Figure 67.  European Digital Biomarkers Market, 2019-2030, $ mn 108
Figure 68. Breakdown of European Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 109
Figure 69. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 110
Figure 70.  Digital Biomarkers Market in Germany, 2019-2030, $ mn 111
Figure 71.  Digital Biomarkers Market in UK, 2019-2030, $ mn 113
Figure 72.  Digital Biomarkers Market in France, 2019-2030, $ mn 115
Figure 73.  Digital Biomarkers Market in Netherlands, 2019-2030, $ mn 117
Figure 74.  Digital Biomarkers Market in Italy, 2019-2030, $ mn 119
Figure 75.  Digital Biomarkers Market in Russia, 2019-2030, $ mn 121
Figure 76.  Digital Biomarkers Market in Rest of Europe, 2019-2030, $ mn 123
Figure 77. Asia-Pacific Digital Biomarkers Market, 2019-2030, $ mn 126
Figure 78. Breakdown of APAC Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 126
Figure 79. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 128
Figure 80.  Digital Biomarkers Market in Japan, 2019-2030, $ mn 130
Figure 81.  Digital Biomarkers Market in China, 2019-2030, $ mn 132
Figure 82.  Digital Biomarkers Market in Australia, 2019-2030, $ mn 134
Figure 83.  Digital Biomarkers Market in India, 2019-2030, $ mn 136
Figure 84.  Digital Biomarkers Market in South Korea, 2019-2030, $ mn 138
Figure 85.  Digital Biomarkers Market in Rest of APAC, 2019-2030, $ mn 140
Figure 86. South America Digital Biomarkers Market, 2019-2030, $ mn 143
Figure 87. Breakdown of South America Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 143
Figure 88. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 144
Figure 89.  Digital Biomarkers Market in Argentina, 2019-2030, $ mn 145
Figure 90.  Digital Biomarkers Market in Brazil, 2019-2030, $ mn 147
Figure 91.  Digital Biomarkers Market in Chile, 2019-2030, $ mn 149
Figure 92.  Digital Biomarkers Market in Rest of South America, 2019-2030, $ mn 151
Figure 93. Digital Biomarkers Market in Middle East and Africa (MEA), 2019-2030, $ mn 153
Figure 94. Breakdown of MEA Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue 153
Figure 95. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 154
Figure 96.  Digital Biomarkers Market in UAE, 2019-2030, $ mn 155
Figure 97.  Digital Biomarkers Market in Saudi Arabia, 2019-2030, $ mn 157
Figure 98.  Digital Biomarkers Market in Israel, 2019-2030, $ mn 159
Figure 99. Growth Stage of Global Digital Biomarkers Industry over the Forecast Period 162

 

Reviews

There are yet no reviews for this product.